PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib
Xia Ding(National Cancer Institute), Todd VanArsdale(Pfizer (United States))
Cited by 14
Related Papers
Essential Role of TRPC6 Channels in G2/M Phase Transition and Development of Human Glioma
|JNCI Journal of the National Cancer Institute|2010|174
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
|Nature Communications|2016|139